Michigan State University main website

Richard Neubig

CRISPR Research Tackles Rare Genetic Disorder in Children

Wednesday, June 13, 2018

Michigan State University scientists will use the latest CRISPR technology to study two extremely rare genetic mutations that leave children severely disabled with seizures and involuntary movements. CRISPR,…

Read More

MSU Scientists Study Gene Causing Children’s Seizures

Thursday, July 27, 2017
Richard Neubig

Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for…

Read More

Promising New Drug Stops Spread of Melanoma by 90 Precent

Wednesday, January 4, 2017
Richard Neubig and Kate Appleton

Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent. The man-made, small-molecule…

Read More

Four MSU Scientists Named AAAS Fellows

Monday, November 23, 2015
Burton, Kirkpatrick, Neubig and Robertson - AAAS fall 2015

This year, four Michigan State University scientists were named AAAS Fellows by the American Association for the Advancement of Science. This national recognition is awarded to researchers for…

Read More

Precision Medicine for Systemic Sclerosis through Pharmacologic Profiling

Thursday, November 12, 2015

Richard Neubig, chair of the Department of Pharmacology and Toxicology at Michigan State University, discusses the potential for pharmacological intervention in scleroderma/systemic sclerosis cases. This presentation was given at…

Read More